Iron Supplementation for Treatment of Iron-Deficiency Anemia in Infants

Treatment Dosing

• The standard therapeutic dose for treatment of presumptive iron-deficiency anemia in a 1-year-old child is 3 mg/kg per day of elemental iron, given as ferrous sulfate drops between meals to maximize absorption 1

• This dose should be continued for the initial 4-week treatment period, after which hemoglobin should be rechecked 1

• If hemoglobin increases by ≥1 g/dL (or hematocrit by ≥3%) after 4 weeks, this confirms iron-deficiency anemia and treatment should continue for 2 additional months 1

Administration Guidelines

• Iron should be administered between meals (not with meals) to optimize absorption, as food can decrease iron bioavailability 1

• Dietary counseling should be provided concurrently to address the underlying problem of inadequate iron intake 1

Adverse Effects and Monitoring

• Common side effects include mild gastrointestinal symptoms (nausea, vomiting, diarrhea), which should not necessarily prompt discontinuation 1

• If the anemia does not respond after 4 weeks despite compliance and absence of acute illness, further laboratory evaluation is needed (MCV, RDW, serum ferritin) 1

• Systemic iron toxicity with hepatocellular damage has been reported with excessive iron administration in pediatric patients 2

Iron Supplementation in Pediatric Patients

Monitoring and Management

• The American Academy of Pediatrics recommends monitoring iron status, including ferritin and hemoglobin, regularly in patients on long-term iron supplementation to prevent both iron deficiency and iron overload, with hemoglobin and iron studies typically rechecked 2-4 weeks after completing iron therapy 3
• The Clinical Nutrition guideline suggests that parenteral iron should only be considered if enteral supplementation fails to maintain adequate iron status, and that further laboratory evaluation, including MCV, RDW, and serum ferritin, should be obtained in non-responders 3

Iron‑Deficiency Anemia Treatment in Infants and Young Children (4 months – 2 years)

Dosing Recommendations

Administration Practices

Treatment Duration and Monitoring

Management of Non‑Response and Counseling

Ferrous Sulfate Dosing and Formulation for Iron‑Deficiency Anemia

Formulation and Elemental Iron Content

• Ferrous sulfate 200 mg tablets contain 65 mg of elemental iron, as reported by the Gut guideline (2021) 5.
• Ferrous sulfate oral drops provide 25 mg of elemental iron per milliliter, according to the Gut guideline (2021) 5.
• For a child weighing roughly 10 kg, the recommended dose of 3 mg/kg/day (≈30 mg elemental iron) corresponds to about 1.2 mL of the ferrous sulfate drops (25 mg/mL) 5.

Management of Inadequate Response in Children

• If a pediatric patient shows an inadequate hemoglobin response after 4 weeks of therapy, the Gut guideline (2021) advises additional laboratory evaluation—including MCV, RDW, and ferritin—to exclude malabsorption, non‑compliance, ongoing blood loss, or concurrent vitamin B12/folate deficiency 5.

Adult Dosing Comparison and Guideline Recommendations

• Adults with iron‑deficiency anemia are recommended to receive 50–100 mg of elemental iron once daily, a dose substantially higher than the weight‑based pediatric regimen, per the Gut guideline (2021) 5.
• The British Society of Gastroenterology (2021) emphasizes once‑daily elemental iron dosing in adults to improve tolerance and compliance, as cited in the Gut guideline 5.

Ferrous Sulfate Tablet Dosing in Pediatric Iron‑Deficiency Anemia

Recommended Pediatric Tablet Dose

• For a child with iron‑deficiency anemia, a single ferrous sulfate tablet containing 65 mg elemental iron (200 mg tablet) may be administered once daily if the child can swallow tablets. This recommendation is based on the dosing guidance presented in Gut (2011)【6】.

Inappropriate Adult Dosing for Children

• The adult regimen of ferrous sulfate 200 mg taken twice daily is not suitable for pediatric patients and should be avoided; pediatric dosing must follow weight‑based recommendations rather than adult schedules. This contraindication is documented in Gut (2011)【6】【7】.